NCT06601972

Brief Summary

Dental manufacturers\' constant tweaks and improvements to composite compositions have resulted in a wider spectrum of restorative materials with positive long-term clinical performance. For example, the creation of bioactive giomer material with proven continuous multi-ion release has been beneficial in avoiding demineralization and imparting acid resistance to enamel and dentin.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
122

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Oct 2024

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Oct 2024Dec 2026

First Submitted

Initial submission to the registry

September 16, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
12 days until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

2 years

First QC Date

September 16, 2024

Last Update Submit

September 16, 2024

Conditions

Keywords

partial caries removalbioactivegiomer

Outcome Measures

Primary Outcomes (1)

  • Success rate

    The primary outcome of the present clinical trial is success rate, expressed as a binary variable indicating whether the restored tooth maintained its pulp vitality after 24 months. Success will be evaluated by a positive response to cold pulp testing, absence of spontaneous pain, no tenderness to percussion, absence of periapical radiolucency.

    From enrollment to the end of treatment at 24 months

Secondary Outcomes (1)

  • Dentin bridge formation

    From enrollment to the end of treatment at 24 months

Study Arms (2)

Giomer

EXPERIMENTAL

Low-shrinkage bioactive material

Procedure: Beautifil II LS (Low-Shrinkage)

Nanohybrid composite

ACTIVE COMPARATOR

Universal Nano-hybrid composite

Procedure: Nanohybrid resin composite

Interventions

The most remarkable feature of this light-cured universal composite for anterior and posterior restorations is its unique shrinkage of 0.85 percent by volume

Giomer

Nanohybrid resin composites are the most popular, because they improve the distribution of fillers in the matrix by combining nanoparticles with submicron particles to achieve better mechanical, chemical, and optical properties

Nanohybrid composite

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • years.
  • Not received antibiotic therapy since 1 month before sampling.
  • Males or Females (Both genders).
  • Co-operative patients approving the trial.
  • Good to fair oral hygiene
  • Class I cavitated lesions in permanent molars (reaching \>1/2 of the dentin on radiographic examination)
  • Absence of spontaneous pain; negative sensitivity to percussion; and absence of periapical lesions (radiographic examination).

You may not qualify if:

  • known allergic reaction to resinous materials.
  • Systemic disease or severe medical complications.
  • Periodontal problem.
  • Bruxism
  • Poor oral hygiene
  • Class II caries lesion
  • Shallow or enamel caries
  • Teeth with periapical lesions.
  • Mobile teeth, arrest caries and non-vital teeth

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Dental Caries

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic Diseases

Central Study Contacts

Omar O Shaalan, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor of conservative dentistry

Study Record Dates

First Submitted

September 16, 2024

First Posted

September 19, 2024

Study Start

October 1, 2024

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

confidentiality, risk of data misinterpretation